Detalhe da pesquisa
1.
Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil.
Endocr J
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710619
2.
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with non-alcoholic fatty liver disease: A prospective randomized study.
Diabetes Obes Metab
; 25(6): 1576-1588, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749298
3.
Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive score.
Endocr J
; 70(11): 1087-1096, 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743517
4.
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.
Cardiovasc Diabetol
; 20(1): 32, 2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33530982
5.
An Evaluation of the Efficacy of Machine Learning in Predicting Thyrotoxicosis and Hypothyroidism: A Comparative Assessment of Biochemical Test Parameters Used in Different Health Checkups.
Intern Med
; 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171877
6.
Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
Thyroid
; 33(3): 373-379, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680759
7.
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin's Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes.
Diabetes Ther
; 10(4): 1509-1521, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172455